The Case Western Reserve University Institutional Biosafety Committee meets once a month on the second Thursday of each month. The meeting location varies. Meetings are open to the public, please contact case-ibc@case.edu for more information. Attendance at meetings will result in your name being recorded in the meeting minutes, which will be made publicly available per NIH requirements.
All new research submissions and requests for continuing review are reviewed by the full committee. Amendments are required for key changes to research plans prior to initiation of changes and, depending on the nature of the change, may be reviewed by the full committee.
The deadline for submissions is four weeks prior to the meeting date.
| Deadline for Submissions | Meeting Date |
|---|---|
| May 11, 2026 | June 11, 2026 |
| June 9, 2026 | July 9, 2026 |
| July 13, 2026 | August 13, 2026 |
| August 10, 2026 | September 10, 2026 |
| September 8, 2026 | October 8, 2026 |
| October 12, 2026 | November 12, 2026 |
| November 10, 2026 | December 10, 2026 |
| December 14, 2026 | January 14, 2027 |
| January 11, 2027 | February 11, 2027 |
| February 11, 2027 | March 11, 2027 |
| March 8, 2027 | April 8, 2027 |
| April 13, 2027 | May 13, 2027 |
Meeting Minutes
In compliance with the NIH Office of Science Policy (OSP) and to promote maximal transparency under the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules, the minutes from the CWRU IBC meetings are listed below.
IBC meeting minutes will be redacted to protect private and/or proprietary information in accordance with Section IV-B-2-a-(6) of the NIH Guidelines.
External IBC administered by Sabai
Notice of Upcoming IBC Meeting for Human Gene Transfer Research
Date: June 15, 2026
Time: 10:00 a.m.
If a member of the general public wishes to attend, please contact the administrators of the Institutional Biosafety Committee at ibcteam@sabaiglobal.com or call Colleen Karlo (Regulatory Contact for the IBC) at 216.368.0838 for information on attending the convened meeting.
Section IV-B-2-a-(6) of the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules states:
When possible and consistent with protection of privacy and proprietary interests, the institution is encouraged to open its Institutional Biosafety Committee meetings to the public.
In compliance with the NIH Office of Science Policy (OSP) and to promote maximal transparency under the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules, the minutes from the IBC meetings administered by Sabai are listed below.
IBC meeting minutes will be redacted to protect private and/or proprietary information in accordance with Section IV-B-2-a-(6) of the NIH Guidelines.